CRDF – cardiff oncology, inc. (US:NASDAQ)
Stock Stats
News
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its price target raised by analysts at HC Wainwright from $13.00 to $17.00. They now have a "buy" rating on the stock.
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update [Yahoo! Finance]
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Cardiff Oncology to Present at Upcoming Investor Conferences
Form 8-K Cardiff Oncology, Inc. For: Feb 27
Form S-3 Cardiff Oncology, Inc.
Form 10-K Cardiff Oncology, Inc. For: Dec 31
Form SCHEDULE 13G/A Cardiff Oncology, Inc. Filed by: PFIZER INC
Form SCHEDULE 13G/A Cardiff Oncology, Inc. Filed by: BlackRock, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.